ESHRE Position statements and papers
Statements, opinions, responses about recent highlights and milestones in the field of reproductive science and medicine can be found in this section .
COVID-19 and assisted reproduction
Revision of the EU legislation on Blood Tissues and Cells
June 2021 - ESHRE is actively involved to ensure that the specificities of medically assisted reproduction are considered and the voice of MAR professionals is heard in the revision of the EUTCD.
Discrimination and bigotry
8 June 2020 - ESHRE reaffirms its opposition to discrimination and bigotry
Spindle transfer
9 July 2019 - Spindle transfer in the treatment of infertility: an ESHRE position statement
Treatment add-ons
3 May 2019 - The responsible use of treatment add-ons in fertility services: a consensus statement
Gene editing in human embryos
22 March 2019 - Moratorium on Gene Editing in human embryos
Safety and Access to Fertility Care
13 December 2018 - ESHRE supports WHO Global Summit on Safety and Access to Fertility Care
Stem cells in reproductive medicine
22 July 2015 - Stem cells in reproductive medicine: ready for the patient?
Prion detection in urinary gonadotropin formulations
ESHRE position statement concerning prion detection in urinary gonadotropin formulations
Birth defects
7 April 2009 - Birth defects in IVF children
Reproductive cloning of human beings
1 August 2007 - Prolongation of Voluntary Moratorium on Reproductive Cloning of Human Beings
Good Clinical Treatment
June 2008 - Good Clinical Treatment in Assisted Reproduction
Ethics statements
Ethics and Law Taskforce Documents
EU Tissues and cells directive